Health Trials

Uterine Leiomyosarcoma

2

Review clinical trials related to Uterine Leiomyosarcoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

This study is to evaluate the efficacy and safety of elacestrant, in participants with advanced estrogen receptor (ER)-positive uterine sarcomas. The name of the study drug involved in this research study is: -Elacestrant (a type of selective estrogen receptor degrader)

Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: May 22, 2026Locations: 1
Eligibility criteria

True abstinence when this is in line with the preferred and usual lifestyle of t... [+11]

Read more
Status: Recruiting

Letrozole in Uterine Leiomyosarcoma

This is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free survival in patients. Patients will receive 2/5 mg of letrozole daily.

Participants needed: 40
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: GOG FoundationUpdated: Mar 31, 2026Locations: 25
Eligibility criteria

Patient or a legally authorized representative must have signed an approved info... [+12]

Read more